标题
Changing the Paradigm for the Treatment and Development of New Therapies for FSGS
作者
关键词
-
出版物
Frontiers in Pediatrics
Volume 4, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2016-03-23
DOI
10.3389/fped.2016.00025
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel Therapies for FSGS: Preclinical and Clinical Studies
- (2015) Laura Malaga-Dieguez et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
- (2015) Jan Bogaerts et al. EUROPEAN JOURNAL OF CANCER
- Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial
- (2015) J. B. Kopp et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Using Population Genetics to Interrogate the Monogenic Nephrotic Syndrome Diagnosis in a Case Cohort
- (2015) M. G. Sampson et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- APOL1 Kidney Risk Alleles: Population Genetics and Disease Associations
- (2014) Sophie Limou et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Utility and Validity of Estimated GFR–Based Surrogate Time-to-Event End Points in CKD: A Simulation Study
- (2014) Tom Greene et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
- (2014) Michael Nauck et al. DIABETES CARE
- Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)
- (2014) Z. Skrivanek et al. DIABETES OBESITY & METABOLISM
- A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov
- (2014) Stuart A Bell et al. Orphanet Journal of Rare Diseases
- Bayesian methods for the design and interpretation of clinical trials in very rare diseases
- (2014) Lisa V. Hampson et al. STATISTICS IN MEDICINE
- Tacrolimus versus Cyclophosphamide in Steroid-Dependent or Steroid-Resistant Focal Segmental Glomerulosclerosis: A Randomized Controlled Trial
- (2013) Hong Ren et al. AMERICAN JOURNAL OF NEPHROLOGY
- Treatment of Idiopathic FSGS with Adrenocorticotropic Hormone Gel
- (2013) J. Hogan et al. Clinical Journal of the American Society of Nephrology
- APOL1 variants and kidney disease in people of recent African ancestry
- (2013) Giulio Genovese et al. Nature Reviews Nephrology
- Structured approach to the elicitation of expert beliefs for a Bayesian-designed clinical trial: a case study
- (2013) Nelson Kinnersley et al. PHARMACEUTICAL STATISTICS
- Clinical Trials In BMT: Ensuring That Rare Diseases and Rarer Therapies are Well Done
- (2012) Susan Shurin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Notice
- (2012) Kidney International Supplements
- Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design
- (2011) Amye Tevaarwerk et al. INVESTIGATIONAL NEW DRUGS
- Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer
- (2011) Aaron S. Kesselheim JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A framework for applying unfamiliar trial designs in studies of rare diseases
- (2011) Samir Gupta et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
- (2011) J. B. Kopp et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pivotal studies of orphan drugs approved for neurological diseases
- (2009) Jun Mitsumoto et al. ANNALS OF NEUROLOGY
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
- (2009) Petra Kaufmann et al. ANNALS OF NEUROLOGY
- Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis
- (2009) G. Fernandez-Fresnedo et al. Clinical Journal of the American Society of Nephrology
- Bayesian clinical trials: no more excuses
- (2009) Mithat Gönen Clinical Trials
- Methods to elicit beliefs for Bayesian priors: a systematic review
- (2009) Sindhu R. Johnson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The future of drug development: advancing clinical trial design
- (2009) John Orloff et al. NATURE REVIEWS DRUG DISCOVERY
- Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases
- (2008) J.H. van der Lee et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Clinical research for rare disease: Opportunities, challenges, and solutions
- (2008) Robert C. Griggs et al. MOLECULAR GENETICS AND METABOLISM
- Adaptive design methods in clinical trials – a review
- (2008) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started